The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study

Neurology. 2004 Apr 13;62(7):1196-8. doi: 10.1212/01.wnl.0000118302.66674.e1.

Abstract

It is unclear how the APOE genotype contributes to the incidence of vascular diseases and dementia. In a population-based sample (n = 6,852) with complete follow-up, APOE was weakly associated with myocardial infarction and not related with stroke. In the absence of epsilon4, the incidence of dementia would be 25.8% lower; in the absence of epsilon2/epsilon3, 2.8% higher. Risk estimates of dementia, specified for age, sex, and APOE, are provided for counseling. APOE is not strongly related to vascular diseases, but contributes substantially to dementia incidence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Aged
  • Apolipoproteins E / genetics*
  • Cohort Studies
  • Dementia / epidemiology
  • Dementia / genetics*
  • Female
  • Genotype
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction / epidemiology
  • Myocardial Infarction / genetics*
  • Netherlands / epidemiology
  • Proportional Hazards Models
  • Risk
  • Risk Assessment
  • Sex Distribution
  • Stroke / epidemiology
  • Stroke / genetics*
  • White People / genetics

Substances

  • Apolipoproteins E